Association between Domperidone Administered via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding Intolerance
One nutritional challenge in critically ill patients is enteral feeding intolerance (EFI), but current prokinetic agents have uncertain efficacy and safety profiles. We conducted a longitudinal, single-center, retrospective study to evaluate the efficacy and safety of domperidone administered via th...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/9/846 |
id |
doaj-2afe823fda174e72b055329f7ec9d3d1 |
---|---|
record_format |
Article |
spelling |
doaj-2afe823fda174e72b055329f7ec9d3d12021-09-26T00:31:50ZengMDPI AGJournal of Personalized Medicine2075-44262021-08-011184684610.3390/jpm11090846Association between Domperidone Administered via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding IntoleranceYisong Cheng0Chaoyue Chen1Hao Yang2Min Fu3Xi Zhong4Bo Wang5Zhi Hu6Min He7Zhongwei Zhang8Xiaodong Jin9Yan Kang10Qin Wu11Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Neurosurgery, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaDepartment of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610064, ChinaOne nutritional challenge in critically ill patients is enteral feeding intolerance (EFI), but current prokinetic agents have uncertain efficacy and safety profiles. We conducted a longitudinal, single-center, retrospective study to evaluate the efficacy and safety of domperidone administered via the feeding tube versus intravenous (IV) metoclopramide among adult patients with EFI. The primary outcome was feeding success, defined as the proportion of patients with average percentage of daily protein prescription >80% of the target dose. The secondary outcomes were safety endpoints. Among 28,814 intensive care unit (ICU) admissions, 552 patients with EFI were included, 38 receiving IV metoclopramide and 514 receiving tube feeding domperidone. The proportion of feeding success in patients receiving tube feeding domperidone and IV metoclopramide was 42.02% and 21.05%, respectively. After 1:2 matching (IV metoclopramide to tube feeding domperidone), the proportion of feeding success was 40.79% in patients receiving tube feeding domperidone. Basically, after matching, there were no differences in any safety endpoints (mortality and length of stay during ICU and hospitalization, organ-support-treatment free days) or adverse events (recurrence of EFI, electrolyte disturbance, abdominal and other symptoms) between the two groups (<i>p</i> > 0.05). A logistic regression analysis in the matched cohort indicated that domperidone administered via the feeding tube was independently associated with feeding success. We found that tube feeding domperidone was efficient in increasing enteral nutrition delivery performance among critically ill adult patients with EFI.https://www.mdpi.com/2075-4426/11/9/846enteral nutritiondomperidonemetoclopramidefeeding successefficacysafety |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yisong Cheng Chaoyue Chen Hao Yang Min Fu Xi Zhong Bo Wang Zhi Hu Min He Zhongwei Zhang Xiaodong Jin Yan Kang Qin Wu |
spellingShingle |
Yisong Cheng Chaoyue Chen Hao Yang Min Fu Xi Zhong Bo Wang Zhi Hu Min He Zhongwei Zhang Xiaodong Jin Yan Kang Qin Wu Association between Domperidone Administered via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding Intolerance Journal of Personalized Medicine enteral nutrition domperidone metoclopramide feeding success efficacy safety |
author_facet |
Yisong Cheng Chaoyue Chen Hao Yang Min Fu Xi Zhong Bo Wang Zhi Hu Min He Zhongwei Zhang Xiaodong Jin Yan Kang Qin Wu |
author_sort |
Yisong Cheng |
title |
Association between Domperidone Administered via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding Intolerance |
title_short |
Association between Domperidone Administered via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding Intolerance |
title_full |
Association between Domperidone Administered via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding Intolerance |
title_fullStr |
Association between Domperidone Administered via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding Intolerance |
title_full_unstemmed |
Association between Domperidone Administered via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding Intolerance |
title_sort |
association between domperidone administered via feeding tube and feeding success in critically ill patients with enteral feeding intolerance |
publisher |
MDPI AG |
series |
Journal of Personalized Medicine |
issn |
2075-4426 |
publishDate |
2021-08-01 |
description |
One nutritional challenge in critically ill patients is enteral feeding intolerance (EFI), but current prokinetic agents have uncertain efficacy and safety profiles. We conducted a longitudinal, single-center, retrospective study to evaluate the efficacy and safety of domperidone administered via the feeding tube versus intravenous (IV) metoclopramide among adult patients with EFI. The primary outcome was feeding success, defined as the proportion of patients with average percentage of daily protein prescription >80% of the target dose. The secondary outcomes were safety endpoints. Among 28,814 intensive care unit (ICU) admissions, 552 patients with EFI were included, 38 receiving IV metoclopramide and 514 receiving tube feeding domperidone. The proportion of feeding success in patients receiving tube feeding domperidone and IV metoclopramide was 42.02% and 21.05%, respectively. After 1:2 matching (IV metoclopramide to tube feeding domperidone), the proportion of feeding success was 40.79% in patients receiving tube feeding domperidone. Basically, after matching, there were no differences in any safety endpoints (mortality and length of stay during ICU and hospitalization, organ-support-treatment free days) or adverse events (recurrence of EFI, electrolyte disturbance, abdominal and other symptoms) between the two groups (<i>p</i> > 0.05). A logistic regression analysis in the matched cohort indicated that domperidone administered via the feeding tube was independently associated with feeding success. We found that tube feeding domperidone was efficient in increasing enteral nutrition delivery performance among critically ill adult patients with EFI. |
topic |
enteral nutrition domperidone metoclopramide feeding success efficacy safety |
url |
https://www.mdpi.com/2075-4426/11/9/846 |
work_keys_str_mv |
AT yisongcheng associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance AT chaoyuechen associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance AT haoyang associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance AT minfu associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance AT xizhong associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance AT bowang associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance AT zhihu associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance AT minhe associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance AT zhongweizhang associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance AT xiaodongjin associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance AT yankang associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance AT qinwu associationbetweendomperidoneadministeredviafeedingtubeandfeedingsuccessincriticallyillpatientswithenteralfeedingintolerance |
_version_ |
1717365863993049088 |